Blood markers for the prognosis of ischemic stroke: A systematic review

Stroke

Volumn 40, Issue 5, 2009, Pages

  Whiteley, William ^a,b   Chong, Wei Li ^a   Sengupta, Anshuman ^a   Sandercock, Peter ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Biomarkers; CRP; Fibrinogen; Prognostic Variables; Stroke

Indexed keywords

4 AMINOBUTYRIC ACID; ADIPONECTIN; ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; ARGININE; BETA THROMBOGLOBULIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; ENDOTHELIN 1; FERRITIN; FIBRINOGEN; GELATINASE A; GELATINASE B; GLUTAMIC ACID; GLYCINE; HOMOCYSTEINE; HYDROCORTISONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MONOCYTE CHEMOTACTIC PROTEIN; MYELIN BASIC PROTEIN; PADGEM PROTEIN; PROTEIN C; PROTEIN S; RESISTIN;

BLOOD LEVEL; CELL ADHESION; CEREBROVASCULAR ACCIDENT; DEATH; DISABILITY; DISEASE SEVERITY; FIBRINOGEN BLOOD LEVEL; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PUBLISHING; REVIEW; SAMPLE SIZE; SYSTEMATIC REVIEW; BLOOD; BRAIN ISCHEMIA; EPIDEMIOLOGY; RECURRENT DISEASE; STATISTICAL ANALYSIS; STROKE; TREATMENT OUTCOME;

BIAS (EPIDEMIOLOGY); BIOLOGICAL MARKERS; BRAIN ISCHEMIA; DATA INTERPRETATION, STATISTICAL; HUMANS; PROGNOSIS; RECURRENCE; STROKE; TREATMENT OUTCOME;

EID: 65549135642     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.528752     Document Type: Review

References (32)

1. Counsell C, Dennis M, McDowall M. Predicting functional outcome in acute stroke: comparison of a simple six variable model with other predictive systems and informal clinical prediction. J Neurol Neurosurg Psychiatry. 2004;75:401-405.
2. Altman DG. Systematic reviews in health care: systematic reviews of evaluations of prognostic variables. BMJ. 2001;323:224-228.
3. Kyzas PA, axa-Kyza D, Ioannidis JPA. Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect. J Natl Cancer Inst. 2007;99:236-243.
4. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM. Reporting recommendations for tumor marker prognostic studies. J Clin Oncol. 2005;23:9067-9072.
5. Hedges LV, Olson RE. Statistical Methods for Meta-analysis. San Diego: Academic Press; 2008.
6. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy and measuring and reducing errors. Stat Med. 1996;15:361-387.
7. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284: 2901-2906.
8. Coull AJ, Lovett JK, Rothwell PM. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004;328:326.
9. Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, Danesh J, Whincup PH. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation. 2006;114:623-629.
10. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Rumley A, Lowe GDO. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulation. 2001;103:2323-2327.
11. Danesh J, Appleby P. Coronary heart disease and iron status: meta-anal-yses of prospective studies. Circulation. 1999;99:852-854.
12. Malik I, Danesh J, Whincup P, Bhatia V, Papacosta O, Walker M, Lennon L, Thomson A, Haskard D. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis. Lancet. 2001;358:971-976.
13. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279: 1477-1482.
14. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ. 2005;330:625.
15. Rothwell PM, Howard SC, Power DA, Gutnikov SA, Algra A, van Gijn J, Clark TG, Murphy MFG, Warlow CP; for the Cerebrovascular Cohort Studies Collaboration. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke. Stroke. 2004;35:2300-2305.
16. Tanne D, Benderly M, Goldbourt U, Haim M, Tenenbaum A, Fisman EZ, Matas Z, Adler Y, Zimmlichman R, Behar S. C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke. 2006;37:1720-1724.
17. Haverkate E, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pctoris Study Group. Lancet. 1997;349:462-466.
18. Emsley HCA, Tyrrell PJ. Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab. 2002;22:1399-1419.
19. Kreisel SH, Bäzner H, Hennerici MG. Pathophysiology of stroke rehabilitation: temporal aspects of neurofunctional recovery. Cerebrovasc Dis. 2006;21:6-17.
20. Denti L, Annoni V, Cattadori E, Salvagnini MA, Visioli S, Merli MF, Corradi F, Ceresini G, Valenti G, Hoffman AR, Ceda GP. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med. 2004;117:312-317.
21. Sotgiu S, Zanda B, Marchetti B, Fois ML, Arru G, Pes GM, Salaris FS, Arru A, Pirisi A, Rosati G. Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol. 2006;13:505-513.
22. Heikkila K, Ebrahim S, Lawlor DA. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health. 2007;61:824-833.
23. Roumen-Klappe EM, den Heijer M, van Uum SHM, van der Ven-Jongekrijg J, van der Graaf F, Wollersheim H. Inflammatory response in the acute phase of deep vein thrombosis. J Vasc Surg. 2002;35:701-706.
24. Grau AJ, Weimar C, Buggle F, Heinrich A, Goertler M, Neumaier S, Glahn J, Brandt T, Hacke W, Diener HC. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German Stroke Data Bank. Stroke. 2001;32:2559-2566.
25. Montaner J, Perea-Gainza M, Delgado P, Ribo M, Chacon P, Rosell A, Quintana M, Palacios ME, Molina CA, varez-Sabin J. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke. 2008;39: 2280-2287.
26. Di Angelantonio E, Fiorelli M, Toni D, Sacchetti ML, Lorenzano S, Falcou A, Ciarla MV, Suppa M, Bonanni L, Bertazzoni G, Aguglia F, Argentino C. Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry. 2005;76:76-81.
27. Fure B, Bruun WT, Thommessen B. Electrocardiographic and troponin T changes in acute ischaemic stroke. J Intern Med. 2006;259:592-597.
28. Sharma JC, Ananda K, Ross I, Hill R, Vassallo M. N-terminal probrain natriuretic peptide levels predict short-term poststroke survival. J Stroke Cerebrovas Dis. 2006;15:6.
29. Jauch EC, Lindsell C, Broderick J, Fagan SC, Tilley BC, Levine SR. NINDS rt-PA Stroke Study Group. Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 2006;37:2508-2513.
30. Counsell C, Dennis M, McDowall M, Warlow C. Predicting outcome after acute and subacute stroke: development and validation of new prognostic models. Stroke. 2002;33:1041-1047.
31. Christensen H, Boysen G, Johannesen HH, Christensen E, Bendtzen K. Deteriorating ischaemic stroke. Cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity, and CT infarction-volume as predictors of deteriorating ischaemic stroke. J Neurol Sci. 2002;201:1-7.
32. Barber M, Langhorne P, Rumley A, Lowe GDO, Stott DJ. D-dimer predicts early clinical progression in ischemic stroke: confirmation using routine clinical assays. Stroke. 2006;37:1113-1115.